Medexus Pharmaceuticals Inc (P731) Ownership - Who Owns Medexus Pharmaceuticals Inc?
Medexus Pharmaceuticals Inc (P731) Ownership Overview
- 8.12% Insiders
- 0.35% Mutual Funds
- 0.03% Other Institutional Investors
- 1.97% ETFs
- 89.52% Public Companies and Individual Investors
The ownership structure of Medexus Pharmaceuticals Inc (DE:P731) stock is a mix of institutional, retail, and individual investors. Approximately 2.36% of the company’s stock is owned by Institutional Investors, 8.12% is owned by Insiders, and 89.52% is owned by Public Companies and Individual Investors.
The ownership structure of Medexus Pharmaceuticals Inc (DE:P731) stock is a mix of institutional, retail, and individual investors. Approximately 2.36% of the company’s stock is owned by Institutional Investors, 8.12% is owned by Insiders, and 89.52% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 02, 2026 | Stephen William Nelson | C$76,041 | |
| Feb 27, 2026 | Stephen William Nelson | C$10,508 | |
| Dec 30, 2025 | Stephen William Nelson | C$94,446 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Kenneth D'entremont | 1,504,807 | Insider | 4.79% | 5,310,464 |
| Stephen William Nelson | 668,588 | Insider | 2.13% | 2,359,447 |
| Exemplar | 566,300 | Institution | 1.80% | 1,998,473 |
| Michael Peter Mueller | 118,222 | Insider | 0.38% | 417,205 |
| Dfa Investment Dimensions Group Inc | 110,700 | Institution | 0.35% | 390,660 |
| Brendon Buschman | 89,538 | Insider | 0.28% | 315,980 |
| Benoit Gravel | 85,368 | Insider | 0.27% | 301,264 |
| Richard Labelle | 85,233 | Insider | 0.27% | 300,787 |
| Dimensional | 53,582 | Institution | 0.17% | 189,091 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Dfa Investment Dimensions Group Inc | 110,700 | Institution | 0.35% | 390,660 |
FAQ
Who Owns Medexus Pharmaceuticals Inc (DE:P731)?
According to the latest TipRanks data, approximately 2.36% of the company's stock is held by institutional investors, 8.12% is held by insiders, and 89.52% is held by public companies and individual investors.
What percentage of Medexus Pharmaceuticals Inc (DE:P731) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.36% of Medexus Pharmaceuticals Inc (DE:P731) stock is held by institutional investors: 0.35% by mutual funds, 1.97% by ETFs and 0.03% by other institutional investors.
What percentage of Medexus Pharmaceuticals Inc (DE:P731) stock is held by retail investors?
According to the latest TipRanks data, approximately 89.52% of Medexus Pharmaceuticals Inc (DE:P731) stock is held by public companies and individual investors.
Who owns the most shares of Medexus Pharmaceuticals Inc (DE:P731)?
Kenneth D'entremont owns the most shares of Medexus Pharmaceuticals Inc (DE:P731).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
